ARTICLE
26 March 2020

USTR Requests Comments On Products Related To The Novel Coronavirus (COVID-19) Concerning Section 301 Tariffs

AG
Akin Gump Strauss Hauer & Feld LLP

Contributor

Akin is a law firm focused on providing extraordinary client service, a rewarding environment for our diverse workforce and exceptional legal representation irrespective of ability to pay. The deep transactional, litigation, regulatory and policy experience we bring to client engagements helps us craft innovative, effective solutions and strategies.
On March 20, 2020, USTR announced that in "an effort to keep current on developments in our national fight against the coronavirus [COVID-19] pandemic,"
United States International Law

On March 20, 2020, USTR announced that in "an effort to keep current on developments in our national fight against the coronavirus [COVID-19] pandemic," the agency "has opened a new docket for members of the public, business, and government agencies to submit comments" on possibly removing duties from additional medical care products of Chinese-origin. According to USTR, this comment process "supplements" the current Lists 3 and 4 exclusion processes and does not replace them.

Read more.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More